Coty Inc. — Form 10-Q summary
Business context and reporting period: Coty manufactures and sells fragrance, color cosmetics, and skin and body care products globally. This filing covers the three months ended September 30, 2023, Coty’s first quarter of fiscal 2024; comparisons are with the three months ended September 30, 2022. Amounts are in U.S. dollars.
Financial results
| Metric | Q1 FY2024 | Q1 FY2023 |
|---|---|---|
| Net revenue | $1,641.4 million | $1,390.0 million |
| Gross profit / margin | $1,041.9 million / 63.5% | $888.7 million / 63.9% |
| Operating income / margin | $197.5 million / 12.0% | $171.9 million / 12.4% |
| Net income | $10.2 million | $134.5 million |
| Net income attributable to Coty Inc. | $1.6 million | $128.6 million |
| Net income (loss) attributable to common stockholders | $(1.7) million | $125.3 million |
| Operating cash flow | $186.2 million | $163.2 million |
| Capital expenditures | $62.2 million | $75.0 million |
- Revenue grew 18% reported and 21% excluding prior-year Russia revenue; management attributed growth to favorable price and mix, foreign exchange, and 1% higher unit volume. Prestige revenue rose 23% and Consumer Beauty revenue rose 10% reported.
- Adjusted operating income, a non-GAAP measure, increased 21% to $302.2 million; adjusted operating margin rose to 18.4% from 18.0%. Adjusted EBITDA increased 17% to $360.3 million, while its margin eased to 22.0% from 22.2%.
- Cash, cash equivalents, and restricted cash totaled $317.7 million at quarter-end. Cash and cash equivalents alone were $280.0 million. Operating cash flow exceeded capital expenditures; operating cash flow included working-capital movements, notably higher receivables and accrued liabilities.
- Total debt was $4,212.1 million, including $40.8 million classified as short-term or current; long-term debt, net, was $4,095.4 million. Coty reported covenant compliance. Approximately 98% of total debt was fixed-rate; the remaining variable-rate exposure was effectively fixed through swaps.
Material changes and drivers
- Revenue growth was led by Prestige fragrances, including Burberry, Hugo Boss, Calvin Klein, Gucci, and Marc Jacobs. Consumer Beauty benefited from color cosmetics, mass fragrance, and skin and body care in Brazil; some China sales volumes declined.
- Gross margin fell about 40 basis points to 63.5%, as higher excess and obsolete inventory costs, designer license fees, and manufacturing and material costs more than offset lower freight costs. Management said pricing contributed approximately 190 basis points, while inflation had a negative impact of approximately 190 basis points.
- SG&A rose 14% in dollars but declined as a share of revenue, from 48.3% to 46.8%, reflecting lower administrative and logistics costs and lower stock compensation as a percentage of sales. Operating margin nevertheless decreased, primarily due to restructuring costs, cost of sales, and promotional spending.
- Net income fell sharply despite higher operating income. Other expense was $76.6 million versus other income of $98.2 million a year earlier, primarily reflecting a smaller favorable fair-value adjustment on the Wella investment and a higher loss on forward repurchase contracts. The effective tax rate increased to 80.0% from 34.1%, including a $24.3 million deferred-tax expense related to a Swiss tax-rate increase.
- Quarter-end balances included goodwill of $3,927.5 million and other intangible assets of $3,688.4 million. Foreign currency translation reduced goodwill by $60.4 million during the quarter.
Outlook, financing, and risks
- Management expected fiscal 2024 revenue growth in the high single digits to low double digits, excluding foreign exchange, the Russia market exit, and early termination of the Lacoste fragrance license. The filing cautions that quarterly results are not necessarily indicative of full-year results.
- Management reported near pre-COVID service levels and expected inflation’s overall impact to ease in coming quarters, while noting continuing exposure to labor and other costs, supply-chain conditions, foreign exchange, consumer demand, and geopolitical developments.
- Coty issued $750 million of 6.625% secured notes due 2030 and €500 million of 5.750% secured notes due 2028, refinanced its revolving credit facilities to 2028, and repaid its Term B facility. The October 2 settlement of a 33 million-share offering generated approximately $348.5 million net, intended primarily for debt repayment, with other possible corporate uses. On October 5, Coty repaid a $31.9 million Brazilian U.S.-dollar credit facility.
- A proposed $150 million sale of a 3.6% Wella stake was terminated in October. Coty retained a 25.9% Wella investment, valued at $1,064.0 million at quarter-end; the valuation uses Level 3 inputs.
- The company began fiscal 2024 restructuring actions, recording $28.6 million of related quarterly charges. It expected approximately $30 million of employee termination costs for the plan. Common-stock dividends remain suspended; management said it expects the suspension to continue until net debt to adjusted EBITDA reaches 2x. Preferred-stock dividends continued.
- Key disclosed exposures include Brazilian tax assessments (approximately $384 million in aggregate stated amounts for open assessments, excluding a closed case), litigation including talc-related claims, tax uncertainties, foreign-exchange movements, debt and refinancing needs, and the extended process to liquidate the Russian legal entity. Coty said losses on the Brazilian assessments were not considered probable and therefore were not accrued.
Important facts for investors to verify
- Whether revenue and adjusted operating performance can be sustained, particularly given volume weakness in parts of China and pressure on gross margin.
- How much of the gap between operating performance and reported net income reflects recurring versus fair-value, financing, and tax items; review Coty’s non-GAAP reconciliations and adjustments.
- Debt-reduction progress and use of the equity-offering proceeds, alongside refinancing terms, interest costs, and covenant headroom.
- The sensitivity of the Wella investment’s Level 3 valuation to its discount rate, growth assumptions, and market multiples, and any future monetization plans.
- Developments in Brazilian tax disputes, related surety bonds, legal proceedings, restructuring cash costs, and Russia wind-down costs.